0001144204-19-009921.txt : 20190225 0001144204-19-009921.hdr.sgml : 20190225 20190225173501 ACCESSION NUMBER: 0001144204-19-009921 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190219 FILED AS OF DATE: 20190225 DATE AS OF CHANGE: 20190225 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hallberg Dane CENTRAL INDEX KEY: 0001768844 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13341 FILM NUMBER: 19630726 MAIL ADDRESS: STREET 1: 400 OYSTER POINT BLVD., SUITE 505 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TITAN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000910267 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943171940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: SUITE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6502444990 MAIL ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: SUITE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 3 1 tv514640_3.xml OWNERSHIP DOCUMENT X0206 3 2019-02-19 0 0000910267 TITAN PHARMACEUTICALS INC TTNP 0001768844 Hallberg Dane 400 OYSTER POINT BLVD., SUITE 505 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 See Remarks Option (Right to Buy) 1.26 2028-10-01 Common Stock 41667 D The option vests in 48 equal monthly installments commencing November 1, 2018. Executive Vice President and Chief Commercial Officer /s/Dane Hallberg 2019-02-25